Emilia Gillis | Authors

Articles

Atezolizumab Makes Inroads in Non–Small Cell Lung Cancer

June 02, 2015

Single-agent atezolizumab (formerly MPDL3280A) had excellent clinical activity in both chemotherapy-naïve and previously treated patients with metastatic non–small cell lung cancer (NSCLC) in the phase II FIR study,